5-Amino-1-(3-chloro-phenyl)-1 H -pyrazole-4-carboxylic acid, 99.0%, 1g

(E)-4-((2-((2-isonicotinoylhydrazono)methyl)phenoxy)methyl)benzoic acid, 97%, 1g

Dihidrato de complexona de alizarina, mínimo 97 %, pa, 10 g, envase de vidrio

1-Butyl-3-vinyl-1H-imidazol-3-ium bromide, 98%, 1g

2-(4-Bromopyridin-2-yl)-2-methylpropanenitrile, 98%, 250mg

5-BROMO-2-FLUORO-3-METHYLBENZOIC ACID, 95.0%, 5g

2,6-Dimethoxynaphthalene>98.0%(GC)5g

Methyl 4-(1-cyanocyclopropyl)-3-fluorobenzoate, 97%, 250mg

3-BROMO-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXYLIC ACID, 95.0%, 1g

lithium 5-(((S)-2-((tert-butoxycarbonyl)amino)-3-(4-carbamoyl-2,6-dimethylphenyl)-N-((S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl)propanamido)methyl)-2-methoxybenzoate dihydrate, 95%, 100mg

2-iso-Propylbenzyl alcohol, 95.0%, 5g

Diethyl 2-isobutylmalonate, 95.0%, 100g

CLINAFLOXACIN, 95%, 25mg